glutamic acid has been researched along with DiGeorge Syndrome in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Booij, J; Ceccarini, J; Roosenschoon, J; Tse, DHY; van Amelsvoort, TAMJ; van Hooijdonk, CFM; Vingerhoets, C | 1 |
| Bagautdinova, J; Delavari, F; Eliez, S; Mancini, V; Saleh, MG | 1 |
| Daly, E; Gudbrandsen, M; Hathway, P; Howes, O; Jauhar, S; McCutcheon, RA; Rogdaki, M | 1 |
| Hernaus, D; Jansen, JF; McAlonan, G; Ramaekers, JG; Tse, DH; van Amelsvoort, T; van Duin, E; van Oudenaren, M; Vingerhoets, C; Zinkstok, J | 1 |
| Tse, DHY; van Amelsvoort, T; Vingerhoets, C | 1 |
| Boot, E; van Amelsvoort, TA | 1 |
1 review(s) available for glutamic acid and DiGeorge Syndrome
| Article | Year |
|---|---|
Neuroimaging correlates of 22q11.2 deletion syndrome: implications for schizophrenia research.
Topics: Brain; Catechol O-Methyltransferase; Diffusion Tensor Imaging; DiGeorge Syndrome; Genetic Predisposition to Disease; Glutamic Acid; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Molecular Imaging; Neuroimaging; Proline Oxidase; Schizophrenia | 2012 |
1 trial(s) available for glutamic acid and DiGeorge Syndrome
| Article | Year |
|---|---|
Glutamatergic and GABAergic reactivity and cognition in 22q11.2 deletion syndrome and healthy volunteers: A randomized double-blind 7-Tesla pharmacological MRS study.
Topics: Adult; Attention; Cognition; Corpus Striatum; Cross-Over Studies; DiGeorge Syndrome; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; gamma-Aminobutyric Acid; Glutamic Acid; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Memory; Riluzole; Young Adult | 2020 |
4 other study(ies) available for glutamic acid and DiGeorge Syndrome
| Article | Year |
|---|---|
The Relationships between Dopaminergic, Glutamatergic, and Cognitive Functioning in 22q11.2 Deletion Syndrome: A Cross-Sectional, Multimodal
Topics: Benzamides; Cognition; Cross-Sectional Studies; DiGeorge Syndrome; Dopamine; Glutamic Acid; Glutamine; Humans; Positron-Emission Tomography; Proton Magnetic Resonance Spectroscopy | 2022 |
Excitatory/Inhibitory Imbalance Underlies Hippocampal Atrophy in Individuals With 22q11.2 Deletion Syndrome With Psychotic Symptoms.
Topics: Atrophy; DiGeorge Syndrome; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Hippocampus; Humans; Neurodegenerative Diseases; Psychotic Disorders | 2023 |
Glutamatergic function in a genetic high-risk group for psychosis: A proton magnetic resonance spectroscopy study in individuals with 22q11.2 deletion.
Topics: Adolescent; Adult; Corpus Striatum; Cross-Sectional Studies; DiGeorge Syndrome; Female; Genetic Predisposition to Disease; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Magnetic Resonance Spectroscopy; Male; Psychotic Disorders; Risk Factors; Thalamus; Young Adult | 2019 |
Riluzole effectively treats psychotic symptoms and improves cognition in 22q11.2 deletion syndrome: A clinical case.
Topics: Adult; Chromosomes, Human, Pair 22; DiGeorge Syndrome; Female; Glutamic Acid; Humans; Proline; Proline Oxidase; Psychotic Disorders; Riluzole; Young Adult | 2019 |